Email this article Anti-Müllerian hormone as an indicator of reproductive health in women with obesity and concomitant polycystic ovary syndrome
- Authors: Durmanova AK1, Otarbaev NK1
-
Affiliations:
- Issue: Vol 88, No 12 (2016)
- Pages: 41-44
- Section: Editorial
- URL: https://ter-arkhiv.ru/0040-3660/article/view/32069
- DOI: https://doi.org/10.17116/terarkh2016881241-44
- ID: 32069
Cite item
Full Text
Abstract
Aim. To investigate the ovarian reserve and a relationship between the level of anti-Müllerian hormone (AMH) with that of hormones in reproductive-aged women with abdominal obesity concurrent with and without polycystic ovary syndrome (PCOS). Subjects and methods. A total of 157 women aged 18 to 45 years with a body mass index (BMI) of more than 30 kg/m2 were examined. The 157 women with abdominal obesity were conventionally divided into 2 groups: 1) 20 with PCOS and 2) 137 without this condition. Morphometric parameters, the indicators of carbohydrate and lipid metabolism, and the levels of hormones, including AMH, were studied. Results. The patients with PCOS had statistically significantly elevated AMH levels (11.26±2.63 ng/ml; p<0.0001). The group of obese patients without PCOS showed a negative correlation of the levels of AMH with those of follicle-stimulating hormone (FSH) (p=0.0004), luteinizing hormone (LH) (p=0.0171), and HOMA-IR (p=0.0572). Conclusion. In reproductive-aged women with abdominal obesity without concomitant PCOS in the presence of insulin resistance, the ovarian reserve decreases and the levels of FSH and LH increase, which leads to accelerated aging processes in the reproductive system. In this case, the patients with PCOS display a significant increase in the AMH levels; therefore, their determination can be used in the algorithm for diagnosing PCOS.
References
- Болотова Н.В., Аверьянов А.П., Дронова Е.Г., Райгородский Ю.М., Левит С.В. Транскраниальные физические методы коррекции нейроэндокринных и церебральных нарушений у девушек-подростков с ожирением. Терапевтический архив. 2012;10:33-36.
- Metwally M, Li T, Ledger W. The impact of obesity on female reproductive function. Obesity Rev. 2007;8(6):515-523.
- Стрижаков А.Н., Давыдов А.И. Железистая гиперплазия эндометрия: принципы диагностики и гормональной терапии. Вопросы гинекологии, акушерства и перинатологии. 2008;7(4):20-24.
- Сперанская Н.В,. Овсянникова Т.В,. Глазкова О.И. Cиндром поликистозных яичников, как причина нарушений репродуктивной функции. Гинекология. 2000;2(2):42-46.
- Маркова Т.Н., Кичигин В.А., Мадианов И.В., Семакина С.М., Диомидова В.Н. Гормонально-метаболические аспекты формирования ожирения и метаболического синдрома в этнических греппах (на примере Чувашской Республики). Терапевтический архив. 2014;5:73-77.
- La Marca A, Giulini S, Tirelli A, Bertucci E, Marsella T, Xella S, Volpe A. Anti-Mullerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology. Human Reprod. 2006;22(3):766-771.
- Cook C, Siow Y, Brenner A, Fallat M. Relationship between serum müllerian-inhibiting substance and other reproductive hormones in untreated women with polycystic ovary syndrome and normal women. Fertil Steril. 2002;77(1):141-146.
- Pigny P, Merlen E, Robert Y, Cortet-Rudelli C, Decanter C, Jonard S, Dewailly D. Elevated Serum Level of Anti-Mullerian Hormone in Patients with Polycystic Ovary Syndrome: Relationship to the Ovarian Follicle Excess and to the Follicular Arrest. J Clin Endocrinol Metab. 2003;88(12):5957-5962.
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reprod. 2004;19(1):41-47.
- Андреева Е.Н., Пищулин А.А., Акмаев Р.И., Карпова Е.А., Деркач Д.А. Сравнительное изучение влияния инсулинорезистентности на андрогенную активность надпочечников у женщин репродуктивного возраста с синдромом поликистоза яичников. Ожирение и метаболизм. 2010;2:29-34.
Supplementary files
